No Seismic Shifts As Torrential Rain Dampens JPM Jamboree

Drug pricing, diversity and US tax reform dominated discussions at JP Morgan. Deals announced at the conference didn't spark much excitement, but attendees were confident that the biopharma sector will still get capital market support.